Stock Events

Stock Events

Seres Therapeutics (1S90.F) Q1 2026 Earnings

12MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-2.13

-0.32

1.5

3.32

Details

Expected EPS

-1.8317964999999998

Actual EPS

-1.545307

Surprise EPS

0.29

Surprise Percent

+15.64%

Description

Seres Therapeutics (1S90.F) has reported earnings of -1.545307 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.